T. Rowe Price Associates’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
24,455
+10,955
| +81% | +$131K | ﹤0.01% | 2543 |
|
|
2025
Q1 | $161K | Sell |
13,500
-4,200
| -24% | -$50.1K | ﹤0.01% | 2711 |
|
|
2024
Q4 | $273K | Hold |
17,700
| – | – | ﹤0.01% | 2538 |
|
|
2024
Q3 | $199K | Hold |
17,700
| – | – | ﹤0.01% | 2657 |
|
|
2024
Q2 | $96K | Sell |
17,700
-7,167
| -29% | -$38.9K | ﹤0.01% | 2765 |
|
|
2024
Q1 | $170K | Buy |
24,867
+1,813
| +8% | +$12.4K | ﹤0.01% | 2664 |
|
|
2023
Q4 | $157K | Buy |
23,054
+688
| +3% | +$4.69K | ﹤0.01% | 2611 |
|
|
2023
Q3 | $113K | Hold |
22,366
| – | – | ﹤0.01% | 2631 |
|
|
2023
Q2 | $162K | Buy |
22,366
+4,666
| +26% | +$33.8K | ﹤0.01% | 2586 |
|
|
2023
Q1 | $150K | Buy |
17,700
+3,700
| +26% | +$31.4K | ﹤0.01% | 2592 |
|
|
2022
Q4 | $119K | Buy |
+14,000
| New | +$119K | ﹤0.01% | 2679 |
|
|
2022
Q2 | – | Sell |
-10,192
| Closed | -$106K | – | 2963 |
|
|
2022
Q1 | $106K | Buy |
+10,192
| New | +$106K | ﹤0.01% | 2826 |
|